Stephan Mielke

7PUBLICATIONS
86CO-AUTHORS
Predictive and prognostic markersHaematologyTransplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 24, 2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.

Elise R A Pennings, Anne M Spanjaart, Frederick W Thielen

|Jul 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL.

Janneke W de Boer, Kylie Keijzer, Suzanne van Dorp

|Nov 20, 2024
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study.

Guillermo Ortí, Christophe Peczynski, William Boreland

|Jul 23, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea Spanjaart, Per Ljungman, Gloria Tridello

|Mar 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

Olaf Penack, Mouad Abouqateb, Christophe Peczynski

|Nov 08, 2023
Latent human herpesvirus 6 is reactivated in CAR T cells.

Caleb A Lareau, Yajie Yin, Katie Maurer

Pageof 2

Frequent Collaborators

2 joint publications

Pere Barba

2 joint publications

Nicolaus Kröger

2 joint publications

Pim Mutsaers

2 joint publications

Mi Kwon